{"id":477181,"date":"2020-04-01T12:14:01","date_gmt":"2020-04-01T12:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=477181"},"modified":"2020-04-01T12:14:01","modified_gmt":"2020-04-01T12:14:01","slug":"parkinsons-disease-epidemiology-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/parkinsons-disease-epidemiology-forecast-to-2030_477181.html","title":{"rendered":"Parkinson\u2019s Disease Epidemiology Forecast to 2030"},"content":{"rendered":"
\"Parkinson\u2019s<\/a><\/p>\n
\n
Parkinson\u2019s Disease Epidemiology<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s \u201cParkinson\u2019s Disease Epidemiology Forecast to 2030\u201d report delivers an in-depth understanding of the disease, historical and forecasted Parkinson\u2019s Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<\/div>\n

DelveInsight launched a new report on Parkinson’s Disease Epidemiology Forecast to 2030<\/a><\/p>\n

Some of the key facts of the report:-<\/strong><\/p>\n

    \n
  1. The total diagnosed Parkinson’s Disease <\/strong>prevalent population in the 7MM is expected to rise to 3,284,084 in 2030, during the study period [2017–2030]. <\/li>\n
  2. The highest diagnosed Parkinson’s Disease prevalent population was in the United States.<\/li>\n
  3. Males are more prominent for developing Parkinson’s Disease in comparison to female.<\/li>\n
  4. Primary Parkinsonism or Idiopathic Parkinson’s cases are prominent in comparison to Secondary or atypical parkinsonism.<\/li>\n<\/ol>\n

     <\/strong><\/p>\n

    Request for sample pages:- https:\/\/www.delveinsight.com\/sample-request\/parkinsons-disease-epidemiology-forecast<\/a><\/p>\n

     <\/p>\n

     \"\"<\/strong><\/p>\n

    Scope of the Report<\/strong><\/p>\n